Showing results (81-90 of 182) with videos related to
Sort By:
Pageof 19
American Journal of Hematology|August 11, 2018
Duvelisib, an oral dual PI3K-δ,γ inhibitor, shows clinical and pharmacodynamic activity in chronic lymphocytic leukemia and small lymphocytic lymphoma in a phase 1 studySusan O'Brien, Manish Patel, Brad S Kahl, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2026
Duvelisib Induces Deep Responses in PTCL: Final Results of the Phase 2 PRIMO Trial of Duvelisib in Relapsed/Refractory Peripheral T-Cell LymphomaNeha Mehta-Shah, Pier Luigi Zinzani, Eric D Jacobsen, et al.Blood|March 8, 2012
Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphomaSteven M Horwitz, Youn H Kim, Francine Foss, et al.Biorxiv : the Preprint Server for Biology|April 15, 2024
Onco-Circuit Addiction and Onco-Nutrient mTORC1 Signaling Vulnerability in a Model of Aggressive T Cell MalignancyXinxin Wang, Andrew E Cornish, Mytrang H Do, et al.Leukemia & Lymphoma|February 8, 2025
Results from an open-label phase 2a study of cerdulatinib, a dual spleen tyrosine kinase/janus kinase inhibitor, in relapsed/refractory peripheral T-cell lymphomaSteven M Horwitz, Tatyana A Feldman, Jing Christine Ye, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2015
Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative ProjectYoun H Kim, Mahkam Tavallaee, Uma Sundram, et al.Blood Advances|May 23, 2020
Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasmsNatasha E Lewis, Kseniya Petrova-Drus, Sarah Huet, et al.Archives of Pathology & Laboratory Medicine|April 26, 2022
Best Practices in CD30 Immunohistochemistry Testing, Interpretation, and Reporting: An Expert Panel ConsensusAlejandro A Gru, Megan S Lim, Ahmet Dogan, et al.Blood Cancer Journal|May 22, 2019
Patterns of survival in patients with recurrent mantle cell lymphoma in the modern era: progressive shortening in response duration and survival after each relapseAnita Kumar, Fushen Sha, Ahmed Toure, et al.Blood Advances|April 10, 2019
Targeting CD47 in Sézary syndrome with SIRPαFcLisa D S Johnson, Swati Banerjee, Oleg Kruglov, et al.Pageof 19